Kind Pharmaceuticals Announces Settlement

HANGZHOU, China, April 16, 2024 /PRNewswire/ -- Today, Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC ("Kind Pharmaceuticals"), together with its Chief Executive Officer Dr. Dong Liu

PR NewswireApr 17 00:17

RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up

Yahoo FinanceApr 12 22:23

Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?

Yahoo FinanceApr 12 21:40

Benign Growth For FibroGen, Inc. (NASDAQ:FGEN) Underpins Stock's 28% Plummet

The FibroGen, Inc. (NASDAQ:FGEN) share price has softened a substantial 28% over the previous 30 days, handing back much of the gains the stock has made lately. For any long-term shareholders, the

Simply Wall StApr 12 19:38

FibroGen, Inc.'s (NASDAQ:FGEN) Latest 43% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures

Key Insights Institutions' substantial holdings in FibroGen implies that they have significant influence over the company's share price A total of 8 investors have a majority stake in the company wi

Simply Wall StApr 4 21:56

FibroGen Falls After Early-stage Data for Prostate Cancer Drug

Seeking AlphaApr 4 03:54